SEC Info - Revance Therapeutics, Inc. - ‘S-3’ on 10/16/15

SEC Info℠

Home

Help

Please Sign In

Revance Therapeutics, Inc. – ‘S-3’ on 10/16/15 – EX-23.1

On: Friday, 10/16/15, at 5:02pm ET · Accession #: 1479290-15-4 · File #: 333-207469

  As Of                Filer                Filing    For·On·As Docs:Size

10/16/15  Revance Therapeutics, Inc.        S-3                    3:340K

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    137K 
                          Pursuant to a Transaction                              
 2: EX-5.1      Opinion re: Legality -- exhibit51                   HTML      8K 
 3: EX-23.1     Consent of Experts or Counsel -- exhibit231         HTML      5K

EX-23.1 — Consent of Experts or Counsel — exhibit231

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 4, 2015 relating to the financial statements, which appears in Revance Therapeutics, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2014. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, California
October 16, 2015

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3’ Filing	Date	Other Filings

Filed on:	10/16/15
	3/4/15	10-K, S-3
	12/31/14	10-K
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/27/15  SEC                               UPLOAD¶    10/18/17    1:151K Revance Therapeutics, Inc.

↑Top

Filing Submission 0001479290-15-000004 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)